secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001140361-24-009040
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 8.01, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BMY closes $13.5B multi-tranche note offering to fund Karuna and RayzeBio acquisitions
--------------------------------------------------------------------------------

- Issued nine tranches totaling $13.5B: Floating Rate Notes (2026) and fixed-rate notes from 2026 to 2064.
- Proceeds partially fund proposed acquisitions of Karuna Therapeutics and RayzeBio; remainder for general corporate purposes.
- Special mandatory redemption at 101% if Karuna deal not closed by June 30, 2025 or company abandons it (excludes 2034, 2044, 2054, 2064 notes).
- Largest tranches: $2.5B 5.200% notes due 2034 and $2.75B 5.550% notes due 2054.
- Underwriting syndicate includes major banks; customary covenants and events of default apply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000114036124009040/0001140361-24-009040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000114036124009040/ef20022028_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-009040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer